Table 2.
Treatment | Events | Years in study | Incidence rate | Incident rate ratio (95% CI) | p value |
---|---|---|---|---|---|
(A) | |||||
No ICS | 383 | 6885 | 0.056 | Reference | |
ICS | 738 | 10,836 | 0.068 | 1.22 (1.08, 1.38) | 0.012 |
(B) | |||||
FP | 437 | 5685 | 0.077 | 1.38 (1.20, 1.58) | <0.001 |
Other ICS | 301 | 5151 | 0.058 | 1.05 | 0.52 |
No ICS | 383 | 6885 | 0.056 | Reference | |
(C) | |||||
FP/Plac | 220 | 2720 | 0.081 | 1.45 (1.19, 1.77) | <0.001 |
FP/tio | 217 | 2964 | 0.073 | 1.31 (1.08, 1.60) | 0.006 |
Other ICS/plac | 153 | 2461 | 0.062 | 1.12 (0.90, 1.38) | 0.29 |
Other ICS/tio | 148 | 2690 | 0.055 | 0.99 (0.79, 1.23) | 0.94 |
No ICS/plac | 184 | 3317 | 0.055 | Reference | |
No ICS/tio | 199 | 3567 | 0.056 | 1.00 (0.82, 1.22) | 0.95 |
ICS Inhaled corticosteroids, FP fluticasone propionate, tio tiotropium, plac placebo